Advanced Search

 

Study ID Status Title Patient Level Data
115830 Completed A Double blind, Placebo controlled, Phase I Dose-ranging Study to Evaluate the Activity of SRT2379 on Endotoxin induced Inflammatory Response in Healthy Male Subjects Study Listed on ClinicalStudyDataRequest.com
115831 Completed Effects of Brain Derived Neurotrophic Factor (BDNF) gene Polymorphism on Brain Imaging and Behavioural Biomarkers of Plasticity
115860 Completed An open-label, randomized, single centre, 4-way crossover study to evaluate the pharmacokinetics of single oral doses of ezogabine/retigabine in healthy adult Taiwanese subjects Study Listed on ClinicalStudyDataRequest.com
115879 Completed A Phase II Multicenter, Parallel-Group, Randomized, Dose-Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Following 12 Weeks of Oral Administration of GSK2336805 With Pegylated Interferon and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 or 4 Hepatitis C Infection Study Listed on ClinicalStudyDataRequest.com
115884 Completed Immunogenicity, safety and reactogenicity study of GSK Biologicals’ pneumococcal vaccine (Synflorix™) when administered to children who are at an increased risk of pneumococcal infection
115885 Completed WEUSKOP5410: A Retrospective Observational Non-Interventional Nested Case Control Study to Evaluate the Risk for Thromboembolic Events Associated with Surgery and Eltrombopag Exposure in the ENABLE Studies
115887 Completed Safety and immunogenicity of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (GSK-580299) in healthy female children 4-6 years old
115892 Completed An Open-Label, Two-Period, Randomized, Crossover Study to Assess the Relative Bioavailability of GSK1120212 Tablet Formulation and the GSK1120212 Pediatric Oral Solution Formulation Following Single-Dose Administration to Adult Subjects with Solid Tumors
115893 Completed A two cohort, open-label study to evaluate the pharmacokinetics of GSK2847065, the metabolite of Retosiban (GSK221149) after single and repeat oral doses, the pharmacokinetics of GSK221149 coadministered with a high fat meal, and the pharmacokinetics of GSK221149 coadministered with an inhibitor of CYP3A4 (Ketoconazole) Study Listed on ClinicalStudyDataRequest.com
115902 Completed A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin from Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects with Acne Vulgaris Study Listed on ClinicalStudyDataRequest.com
115912 Completed A multi-center, open-label study of GSK548470 (Tenofovir Disoproxil Fumarate) in patients with compensated chronic hepatitis B with poor response to other drugs
115918 Completed An open-label study to assess the immunogenicity and safety of GSK Biologicals’ hepatitis B vaccine, Engerix™-B in adults with or without type 2 diabetes mellitus Study Listed on ClinicalStudyDataRequest.com
115919 Terminated An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with mild to moderate systemic lupus erythematosus Study Listed on ClinicalStudyDataRequest.com
115926 Completed Drug Use Investigation for ROTARIX
115927 Completed Special Drug Use Investigation for ROTARIX
115938 Completed A multi-center, randomized, double-blind, dose-ranging study to evaluate GSK573719 in combination with fluticasone furoate, fluticasone furoate alone, and an active control of fluticasone furoate/vilanterol combination in subjects with asthma Study Listed on ClinicalStudyDataRequest.com
115951 Completed A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects with Mild to Moderate Ulcerative Colitis Study Listed on ClinicalStudyDataRequest.com
115954 Completed Evaluation of pharmaceutical bioequivalence of Amoxicillin trihydrate - Clamoxyl 500mg/5mL (Glaxo Wellcome Production.) in the form powder for oral suspension versus Amoxil ® 500mg/5mL (GlaxoSmithKline Mexico SA) in the form of powder for oral suspension in healthy volunteers and fasting, using techniques of Liquid Chromatography
115959 Completed A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid after Topical Administration of GSK2585823 in Japanese Subjects with Acne Vulgaris Study Listed on ClinicalStudyDataRequest.com
115981 Terminated A post marketing surveillance study to monitor the risk of urinary retention in retigabine users
115983 Completed Rechallenge Analysis: Detection of Potential Drug-Induced Liver Injury using Kaiser California Database
115984 Completed Phase 1 Study of the BRAF Inhibitor Dabrafenib +/- MEK Inhibitor Trametinib in Combination with Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma
115991 Active, Not Recruiting A Phase II, Multi-centre Study Investigating the Safety and Efficacy of Ofatumumab and Bendamustine Combination in Patients with Untreated or Relapsed Chronic Lymphocytic Leukaemia (CLL)
115992 Completed Two-dose primary vaccination with either GSK Biologicals' 10-valent pneumococcal vaccine (Synflorix™) or Pfizer’s Prevenar 13™ or both vaccines followed by a booster dose of Synflorix™
115997 Completed Effect of influenza vaccine against mismatched strains: Systematic Review

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.